FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

IBL C1Q-CIC CIA TEST

K Number: K032254 · Decision Aug 29, 2003
Classifications
1
FEI Numbers
9
Registration Numbers
9
Same Product Code
27
Applicant Total
6
Review Days
38

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
IBL C1Q-CIC CIA TEST
K Number
K032254
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.5240
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Ibl GmbH
Date Received
July 22, 2003
Decision Date
August 29, 2003
Product Code
DAK
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DAK Complement C1q, Antigen, Antiserum, Control

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DAK), ordered by most recent decision date.

View all

Other Clearances by Ibl GmbH

K Number Device Name
K051969 TRICAT RIA (ADRENALIN/NORADRENALIN/DOPAMINE); KATCOMBI RIA (ADRENALIN/NORADRENALIN); NORADRENALIN RIA
K041349 LUMINESCENT IMMUNOASSAY KIT FOR THE DETECTION OF ESTRADIOL IN SALIVA AND SERUM
K040923 LUMINESCENT IMMUNOASSAY KIT FOR THE DETECTION OF PROGESTERONE IN SALIVA
K033786 LUMINESCENT IMMUNOASSAY KIT FOR THE DETECTION OF TESTOSTERONE IN SERUM AND SALIVA
K032796 IBL C3D-CIC EIA TEST